What is IVBXF's gross margin?

Innovent (IVBXF) has a gross margin of 85% and a net margin of 15%.

What is IVBXF's P/E ratio?

IVBXF's P/E ratio is 116.0 with ROE of 14%.

Where can I see IVBXF's full financials?

See Innovent (IVBXF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Innovent (IVBXF) Financials — Revenue, Earnings, Cash Flow

Also trades as: 1801.HK (HKSE) · $vol 173M

$12.80

+0.29 (+2.33%)

Weekly Expected Move ±14.3%

$9 $11 $13 $15 $16

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 54 · $22.3B mcap · 1.61B float · 0.0002% daily turnover · Short 55% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$27B

Revenue

+115.6% YoY

$2B

Net Income

+188.6% YoY

$14B

Free Cash Flow

+516.8% YoY

85.0%

Gross Margin

22.1%

Op. Margin

14.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE14.2%

ROA7.6%

ROIC93.7%

Valuation

P/E116.0

P/B6.8

EV/EBITDA0.0

Leverage

Debt/Equity0.11

Current Ratio2.68

Interest Cov.52.2x

Quality Scores

Piotroski F8/9

Altman Z—

Beneish M-2.92